Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up

S. Daiana, A. Meyer, J. Rakic, L. Boeck, A. Scherr, M. Tamm (Basel, Switzerland)

Source: International Congress 2014 – Markers
Session: Markers
Session type: Thematic Poster Session
Number: 564
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Daiana, A. Meyer, J. Rakic, L. Boeck, A. Scherr, M. Tamm (Basel, Switzerland). Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up. Eur Respir J 2014; 44: Suppl. 58, 564

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Stable state MR-proadrenomedullin level in COPD patients; a validation study
Source: International Congress 2014 – Comorbidities
Year: 2014


COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study
Source: International Congress 2014 – Markers
Year: 2014

Adrenomedullin optimizes mortality prediction in COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014


Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013

Mortality risk prediction in COPD by a prognostic biomarker panel
Source: Eur Respir J 2014; 44: 1557-1570
Year: 2014



COPD related fatigue (COPD-RF) as a patient centred outcome tool in COPD: Various predictors and its correlation with other outcome parameters
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016


Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015

Simple functional performance tests as predictors of clinical outcomes in COPD
Source: International Congress 2015 – Best abstracts in functional capacity in chronic lung diseases
Year: 2015



Mortality predictors in stable COPD
Source: International Congress 2014 – Predictors
Year: 2014


Risk scores for predicting death in COPD patients
Source: International Congress 2016 – Highlights in the management of COPD and beyond
Year: 2016


Prognostic assessment in chronic obstructive pulmonary disease using copeptin: A simplified risk index
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015


Comparing non-invasive cardiovascular risk assessment tools in COPD patients: Validation with CV events
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014


Circulating copeptin is associated with mortality irrespectively of exacerbation rate in stable COPD
Source: International Congress 2014 – COPD - from biomarkers to novel therapeutic opportunities
Year: 2014

Introducing a new prognostic instrument for long-term mortality prediction among COPD patients - the CADOT index.
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019


Impact of different spirometric definitions on COPD prevalence and biomarkers in a population-based sample up to age 90
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015

Detecting undiagnosed COPD: Using routine primary care data to select and validate candidate variables for COPD risk prediction
Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care
Year: 2013


Clinical phenotyping of COPD patients: a simple tool with prognosis value
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Year: 2018



LATE-BREAKING ABSTRACT: Biomarkers of ECM turnover and clinical relevant outcomes in COPD: Results of the multicenter PROMISE study
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015

SP-D as a biomarker for COPD in the Lebanese population
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014


Predicting risk of undiagnosed COPD: development and validation of the TargetCOPD score
Source: Eur Respir J, 49 (6) 1602191; 10.1183/13993003.02191-2016
Year: 2017